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Abstract
Background: Keratin 15 (K15) is a type I keratin that is used as a marker of stem cells. Its expression is restricted to the basal
layer of stratified epithelia, and the bulge in hair follicles. However, in certain clinical situations including oral lichen planus,
K15 is induced in suprabasal layers, which is inconsistent with the role of a stem cell marker. This study provides insights
into the mechanisms of K15 expression in the basal and differentiating keratinocytes.
Methodology/Principal Findings: Human keratinocytes were differentiated by three different methods; suspension in
methylcellulose, high cell density and treatment with phorbol ester. The expression of mRNA was determined by
quantitative PCR and protein by western blotting and immunostaining. Keratinocytes in suspension suppressed b1-integrin
expression, induced differentiation-specific markers and K15, whereas FOXM1 (a cell cycle regulated protein) and K14 were
downregulated. Rescuing b1-integrin by either fibronectin or the arginine-glycine-aspartate peptide suppressed K15 but
induced K14 and FOXM1 expression. Specific inhibition of PKCd, by siRNA, and AP-1 transcription factor, by TAM67
(dominant negative c-Jun), suppressed K15 expression, suggesting that PKC/AP-1 pathway plays a role in the
differentiation-specific expression of K15. The basal cell-specific K15 expression may involve FOXM1 because ectopic
expression of the latter is known to induce K15. Using chromatin immunoprecipitation, we have identified a single FOXM1
binding motif in the K15 promoter.
Conclusions/Significance: The data suggests that K15 is induced during terminal differentiation mediated by the down
regulation of b1-integrin. However, this cannot be the mechanism of basal/stem cell-specific K15 expression in stratified
epithelia, because basal keratinocytes do not undergo terminal differentiation. We propose that there are two mechanisms
regulating K15 expression in stratified epithelia; differentiation-specific involving PKC/AP-1 pathway, and basal-specific
mediated by FOXM1, and therefore the use of K15 expression as a marker of stem cells must be viewed with caution.
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Introduction
In the epidermis, the basal keratinocytes are unique due to their
attachment to the basement membrane and they constitute the
major proliferating cell population. Some of the basal keratino-
cytes are stem cells that are characterised by their longevity and
clonogenicity. These cells are responsible for tissue homeostasis
and regeneration of epidermis following injury [1,2,3,4,5,6]. As the
stem cells divide, they produce transit-amplifying (TA) cells, which
provide a constant supply of ‘committed’ cells to replenish those
lost during differentiation (reviewed in [7]). The committed
keratinocytes downregulate integrins to become less adhesive,
move to the suprabasal compartment and continue their upward
movement until they are terminally differentiated [8] and shed off.
This produces several layers of keratinocytes, at different stages of
differentiation, which provide a protective barrier. The different
layers of epidermis can be identified by the expression of keratins,
which are a very large family of proteins (49 genes in the human
genome [9]) that form heteropolymers of type I (acidic) and type II
(basic/neutral) polypeptides in ‘soft’ and ‘hard’ epithelia [10]. A
member of each type is necessary to form filaments and the
pairwise expression is highly differentiation specific. For example,
the basal keratinocytes express keratins K5, K14 and K15,
whereas differentiating keratinocytes in the epidermis express
keratins K1 and K10 [11,12] and in the mucosae they express
keratins K4 and K13 [13]. K6, K16, K9 and K17 are expressed in
palmoplantar epidermis [14] and also in psoriasis, hypertrophic
and keloid scars and in some epidermal tumours [15,16]. The
transcription of basal keratins is switched off as soon as the basal
keratinocytes move into the suprabasal compartment with
concomitant induction of differentiation-specific keratins [11,17].
K15 is a type I keratin which does not have its own type II
expression partner for filament assembly and shares the type II
partner, K5, with K14 [18]. This protein attracted the investiga-
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epidermis, and it had a molecular weight similar to K14, so it
could only be separated by 2-D gel electrophoresis [11,19]. The
first polyclonal antibody against K15 was described in 1995/96 for
tissue expression studies [18,20]. Later work used C8/144B,
LHK15 and a cross reacting LC18N monoclonal antibodies,
which established that K15 was specifically expressed in the basal
keratinocytes of most stratified epithelia [21,22,23].
In the epidermis, K15 expression is discontinuous in adults, with
strongest staining in rete-ridges and weakest in the dermal papillae
[21,24]. There are several lines of evidence to suggest that K15 is a
marker of stem cells. First, K15 is strongly expressed in the bulge
compared with the rest of the follicle [21,23,25]. Second, K15
expression has been used to detect limbal stem cells on ocular
surfaces [26]. Third, K15+ keratinocytes express lower levels of
the pro-apoptotic gene Bax, but higher levels of anti-apoptotic
genes than the K15- cells, which is consistent with their stem cell
nature [24]. Fourth, K15 promoter was able to target b-
galactosidase to the bulge [27] and bulge cells expressing K15
promoter driven GFP reconstituted entire epidermis and had
higher proliferation potential [28]. Fifth, the Lgr5+ cells in the
bulge, capable of regenerating the entire follicle, were K15+ [29].
These observations are inconsistent with other reports that do not
support K15 as a marker of stem cells. For example, in sheep hair
follicles K15 is expressed in the outer root sheath except in the
bulge [30]. Furthermore, in mucosal epithelia, the K15 expression
is uninterrupted throughout the basal layer and it is unlikely that
every basal cell would be a stem cell. This may indicate that in
mucosae either the stem cell zone has expanded or it is
heterogeneous containing stem and non-stem cells as in the bulge
[29,31]. Nevertheless, this indicates that K15 expression shows
variation in different epithelia in a species-specific fashion.
The expression of K15 has been reported to change in a large
number of human diseases, for example, K15 is increased in basal
cell carcinoma (BCC) but it is suppressed in squamous cell
carcinoma [22,32,33,34]. In hyperproliferating conditions, such as
during wound healing, pathological scarring and also in some
psoriatic samples, the K15 expression is suppressed, suggesting
that the cellular environment inside activated keratinocytes may
not be conducive to K15 expression [21,22,35]. The downregu-
lation of K15 in inflammatory conditions is consistent with the
reported suppression of K15 transcription by activation-specific
growth factors and cytokines including the transforming growth
factor-b, the tumour necrosis factor-a, the epidermal growth factor
and keratinocyte growth factor [36]. These reports also suggest
that K15 may not be a reliable stem cell marker on its own,
especially in diseased epithelia [35,37].
The regulation of K15 is more complex than other keratins and
appears to depend on the presence of other keratins, especially the
level of K14. For example, increased expression of K15 has been
observed in K14 knockout mice and also in EBS patients lacking
K14 [18,20]. The level of K15 expression and its localisation in
the basal layer has also been reported to change with age [18,38].
In certain stratified epithelia, such as the oesophagus, and in
certain clinical situations, such as oral lichen planus, K15 is
expressed in the suprabasal layers [22,39,40]. This, together with
the reported induction of K15 synthesis in keratinocytes at high
cell densities [22,41], suggests that K15 can also be expressed in
differentiating keratinocytes. In a detailed analysis of the K15
promoter (1250 bp upstream region), Radoja and co-workers
showed that C/EBP-b, AP-1, thyroid hormone and IFN-c
induced the K15 promoter, whereas retinoic acid, glucocorticoid
receptors, and NF-kB suppressed it [42]. These studies, although
highly informative, do not explain the mechanism of basal and
suprabasal expression of K15 in stratified epithelia. No study thus
far has investigated the molecular mechanism regulating the
differentiation-specific expression of K15. Here we provide the
first mechanistic evidence that K15 expression could be induced
by differentiation through PKCd and AP-1. We also show that the
basal cell (or stem cell) specific expression of K15 involves a
different mechanism, perhaps mediated by the cell cycle regulated
transcription factor FOXM1. This study will help resolve
conflicting data in the literature on the expression of K15 and
cautions to its use as a marker of stem cells.
Results
Induction of Keratin K15 in Differentiating Human
Keratinocytes
To study keratin gene regulation during differentiation, we
suspended keratinocytes (N-Terts) in 1.3% (w/v) methylcellulose
and we were expecting a downregulation of K14 and K15 genes
because both were basal-specific keratins. However, to our surprise
we observed a time-dependent downregulation of K14 but an
upregulation of K15 gene transcription (Fig. 1a). To demonstrate
that keratinocytes were indeed undergoing differentiation in
methylcellulose, we measured a series of differentiation-specific
genes K1, K10, cornifin and involucrin. As shown in figure 1a, the
transcription of differentiation-specific genes increased with time
and reached a maximum at 24 h. The transcriptional induction of
K10 and K15 displayed a lag phase, which was absent in other
genes (Fig. 1a), indicating that their induction perhaps required
synthesis of additional factors. Methylcellulose suspension is
known to induce terminal differentiation by downregulating b1-
integrin [8,43]. To demonstrate that keratinocyte differentiation
was indeed mediated by b1-integrin, we measured b1 expression
in suspended keratinocytes. As shown in figure 1b, more than 90%
b1-integrin transcription was suppressed after 24 h of suspension
in methylcellulose. The suspension-induced differentiation in-
creased the level of K15 as well as involucrin proteins, whereas
K14 protein was not influenced significantly (Fig. 1c). This was
supported by the immunofluorescence staining data shown in
figure 2. Suspension of single cell N-Terts in methylcellulose
induced cell aggregation, which stained much more strongly for
K15, involucrin and cornifin (Fig. 2). On the other hand, the
staining for K14 was not influenced by suspension.
When N-Terts were grown in the RM+ medium, containing 50-
fold more EGF than the SFM, the expression profile became
biphasic, an initial de-differentiation phase followed by the
differentiation phase (Fig. S1a). Substitution of N-Terts with
normal human primary epidermal or immortalized keratinocytes
(HaCaT) in the suspension culture only changed the level of gene
induction, without affecting the overall pattern of K15 induction
or expression of the differentiation markers (Fig. S1b).
Suppression of K15 Expression in Suspension Culture by
Fibronectin and RGD Peptide
Engaging b1-integrin with fibronectin has been shown to
suppress methylcellulose induced terminal differentiation of
keratinocytes [43]. To demonstrate that K15 expression was
indeed sensitive to keratinocyte differentiation, we added 100 mg/
ml fibronectin in the suspension culture, which suppressed
terminal differentiation as shown by the decrease in the level of
cornifin mRNA (Fig. 1d). The expression of FOXM1 (isoform B),
which is known to be downregulated at the onset of differentiation
[44], was increased by fibronectin, confirming that differentiation
was being suppressed. Interestingly, the expression of K15 was also
suppressed by fibronectin (Fig. 1d), suggesting that.
Differentiation-Specific Expression of K15
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e38599Differentiation-Specific Expression of K15
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38599K15 expression was sensitive to differentiation under these
conditions. The fibronectin effect was reproduced by 5 mM
arginine-glycine-aspartate (RGD) peptide, which is known to
mimic fibronectin [43,45], except that the peptide was more
effective, perhaps due to its low molecular weight. As expected, the
expression of K14 and FOXM1B, which are reduced in
suspension, were increased by fibronectin and the peptide (Fig. 1e).
Induction of K15 Expression at High Keratinocyte Density
Keratinocytes are reported to undergo differentiation at a high
cell density [41]. To investigate how cell density-induced
keratinocyte differentiation influences K15 expression, we mea-
sured K15 mRNA in N-Terts, cultured to high density. We
observed that at low calcium (0.09 mM), the transcription of K10,
K1 and cornifin increased 1774, 120 and 120 fold respectively, as
the cell density increased from 20 to 95% (Fig. 3a). The basal
keratins K14 and K15 were also induced at high cell densities,
with K15 showing a much higher expression (14 fold) than K14
(5.1 fold). The FOXM1B expression was slightly reduced (about
10%) as the cell density approached confluence. This pattern
remained unchanged at 1.8 mM calcium (Fig. 3b).
To investigate if increasing cell-cell interaction/adhesion was
enough to trigger differentiation and K15 expression, we plated N-
Terts at different densities (from 20–100%) in low calcium
(0.09 mM) and after 24 h analyzed the expression of K1, K10,
cornifin, K14, K15 and FOXM1B. As shown in figure 3c, the
expression pattern was almost identical to that seen when the cells
were allowed to grow for several days to reach confluence.
A comparison of protein expression in N-Terts was carried out
at low and high cell densities using immunofluorescence staining.
As shown in figure 4, cells at low density expressed reduced K15
(Fig. 4, compare a with b) but the expression of involucrin (Fig. 4e,
f) was not significantly different at low and high cell densities. K14
expression was significantly reduced at high cell density (Fig. 4c, d).
The cells at the low density expressed K15 as small globules spread
in the cytoplasm whereas at the high cell density only filament
staining was predominantly observed (Fig. 4i, j).
To determine if density-dependent induction of K15 was unique
to N-Tert, we replaced N-Terts with a spontaneously immortal-
ized human keratinocyte, HaCaT, in these experiments. The
HaCaT cells were plated at 30% or at 95% confluence and after
24 h analyzed for the mRNA expression of K1, K10, K14, K15,
cornifin and FOXM1B. The differentiation-specific markers K1
and K10 were induced 20 and 5 fold, respectively, whereas
cornifin was only increased 2 fold. FOXM1B expression was not
influenced, but K14 was induced 2 fold (Fig. S2a). The protein
expression was increased for K14 but not significantly for K15
(Fig. S2b).
Role of PKC in the Induction of K15 Expression
Exposure of keratinocytes to PMA has been reported to activate
PKC and induce differentiation [46]. To investigate if PMA-
Figure 1. Induction of K15 expression in keratinocytes suspended in methylcellulose solution. (a) N-Terts growing in SFM were
suspended in DMEM +20% FCS containing 1.3% (w/v) methylcellulose. At different time, total mRNA was isolated, converted into cDNA and used to
determine the expression of K1, K10, cornifin, involucrin, K14 and K15 by real-time absolute qPCR. (b) Downregulation of b1-integrin following 24 h
incubation of N-Terts in methylcellulose. (c) Expression of K15, K14 and involucrin protein by western blotting following incubation of N-Terts in
suspension at 0 and 24 h. (d) Influence of 100 mg/ml fibronectin on the time course of keratinocyte differentiation as measured by the expression of
K15, K14, cornifin and FOXM1B. (e) Comparison of fibronectin (Fib) and RGD peptide (RGD) on gene transcription in suspension culture at 0 and 24 h.
The 0 h cells were used for mRNA extraction soon after trypsinisation before being suspended in methylcellulose. Each bar represents the
mean6SEM where n=3. (P,0.01, very significant, **; P,0.001, extremely significant, ***).
doi:10.1371/journal.pone.0038599.g001
Figure 2. Induction of K15 in terminally differentiated N-Tert keratinocytes. N-Terts growing in SFM were suspended in DMEM +20% FCS
containing 1.3% (w/v) methylcellulose. At 24 h the cells were harvested and washed with PBS before being suspended in 20–30 ml FCS. A 3–4 ml
aliquot was streaked on glass slides. At the same time freshly trypsinised N-Terts were also streaked and used as 0 h control. The cells were dried in
air, fixed in formaldehyde and immunostained with different monoclonal antibodies as described in the ‘Materials and Methods’ section. K15 (a, b),
K14 (c, d), Involucrin (e, f), Cornifin (g, h). All slides were photographed at the same magnification. The cells in b, d, f and h were difficult to focus
because they underwent aggregation in methylcellulose (magnification bar =20 mm).
doi:10.1371/journal.pone.0038599.g002
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different concentrations (0–500 nM) of PMA and observed
induction of cornifin and involucrin whereas K1, K10 and
FOXM1B were suppressed. The expression of K14 was not
influenced, whereas K15 was induced about 10 fold at 10 nM
PMA (Fig. 5a). These data were confirmed by western blotting
where K15 was induced by PMA, K14 was uninfluenced and
involucrin was only slightly induced (Fig. 5b). Immunostaining of
N-Terts treated with 10 nM PMA showed enhanced expression of
K15, involucrin and cornifin, whereas expression of K14 was only
slightly reduced (Fig. 5e - l).
To show that suspension-induced K15 expression also involves
PKC activation, we suspended N-Terts in methylcellulose in the
presence of a highly specific PKC inhibitor GF109203X [47]. As
shown in figure 5c, 5 mM GF109203X increased K14 and
FOXM1B expression, whereas involucrin and K15 were massively
suppressed. The expression of K15 protein was also suppressed by
GF109203X but K14 was not influenced (Fig. 5d), suggesting that
the inhibitor was highly selective for K15. These observations
highlighted that the mechanisms regulating K14 and K15 genes
were different.
Knocking Down PKCd but not PKCg Suppresses
Suspension-induced K15 Expression
Epidermal keratinocytes express five different isoforms of PKC
[48]. To determine which PKC isoform is involved in suspension-
induced K15 expression, we first identified the PKC isoforms that
were transcribed following suspension of N-Terts in methylcellu-
lose. Only PKCd and PKCg transcriptions were induced more
than 2 fold and the rest did not change (Fig. S3).
Using siRNA, we independently knocked-down PKCd or
PKCg to determine its effect on suspension-induced K15
expression. We found that knocking down PKCd to about 80%
reduced K15 transcription by about 50%, whereas knocking down
PKCg was ineffective (Fig. 6).
Role of AP-1 in Suspension-induced K15 Expression
One of the mechanisms of terminal differentiation of keratino-
cytes involves the MAP kinase pathway that leads to induction of
AP-1, a transcription factor that is a complex of a member of the
Jun and Fos families of proteins [49]. To investigate whether AP-1
activation is required for K15 transcription in the suspension
culture, N-Terts were treated with different concentrations of a
highly specific AP-1 inhibitor SR11302 [50] followed by the
methylcellulose suspension. As the concentration of the inhibitor
was increased from 0 to 2 mM, the K15 transcription decreased by
about 75%, without influencing K14. Further increasing the
inhibitor from 2–5 mM did not change K15, but the K14
expression was increased (Fig. 7b). These experiments further
highlight differences in the regulatory mechanisms of K14 and
K15, although both are basal-specific type I keratin genes.
To further demonstrate the role of AP-1 in K15 expression,
HaCaT cells were transduced with the retrovirus expressing
TAM67, the dominant negative form of c-Jun, or pLPC vector.
Expression of TAM67 significantly inhibited the suspension-
induced HaCaT differentiation as shown by a reduction in
cornifin expression compared with the vector control (Fig. 7c). The
expression of K15 followed the same trend as cornifin, but K14
and FOXM1B were marginally influenced (Fig. 7c). This
complements the data shown in figure 7b using the AP-1 inhibitor
SR11302.
Role of FOXM1B in K15 Expression
We have recently shown that the ectopic expression of
FOXM1B in normal keratinocytes dose-dependently induces
K15 gene transcription [44]. In order to investigate if FOXM1B
binds to the K15 promoter, we performed X-chromatin immu-
noprecipitation (X-ChIP) using a highly specific FOXM1B
antibody. The immunoprecipitated K15 promoter fragments were
quantified by qPCR, using primers specific for seven different
regions of the promoter (Fig. 8a; Table S1). As shown in figure 8(b,
Figure 3. Induction of K15 transcription in keratinocytes cultured at increasing cell densities. N-Terts growing in SFM at low (0.09 mM)
(a) and high (1.8 mM) (b) calcium concentrations were allowed to reach the desired confluence before being used for expression of K1, K10, K14, K15,
cornifin and FOXM1B. In (c) N-Terts at low calcium (0.09 mM) were plated at the required density, allowed to attach for 24 h, after which they were
used to measure mRNA levels by qPCR. Each bar represents the mean6SEM where n=3.
doi:10.1371/journal.pone.0038599.g003
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precipitated up to 38 fold in excess, compared to the surrounding
fragments. A careful search of the K15 promoter identified a single
motif (22177–2155) in this fragment, which had 75% sequence
identity with the published binding motif for FOXM1B [51]
(Fig. 8a).
Discussion
This is the first study to show that K15 is induced when
keratinocytes are differentiated by anchorage deprivation in
methylcellulose, or at a high cell density or by PMA. This was
unexpected because K15 expression in vivo is confined to the basal
layer; in the epidermis the expression is mostly restricted to the
rete ridges, whereas in oral and other internal epithelia, it is
continuous in the basal layer [21,52]. However, in some stratified
epithelia, such as the oesophagus, K15 is normally expressed in the
basal and suprabasal layers [18,22,39]. In addition, K15 is
expressed in the suprabasal layers of varicella zoster virus (VZV)
blisters (Manu Singh, unpublished observation) and in oral lichen
planus [40]. Furthermore, exposure of freshly cut skin sections to
thyroid hormone or interferon gamma appears to induce K15
expression in the suprabasal layers [42]. This perhaps suggests that
a mechanism for differentiation-specific expression of K15 exists in
stratified epithelia that can be triggered by stress. However, the
reason why K15 is not expressed in the suprabasal layers of the
epidermis and oral epithelia is not clear. It is conceivable that a
hitherto unidentified mechanism restricts K15 expression to the
basal layer.
Of all the methods used in this study, only the methylcellulose
suspension culture leads to irreversible loss of proliferation with the
formation of corneocytes (dead cells), a process reminiscent of the
terminal differentiation in skin [8,43,53]. The gene expression
Figure 4. Induction of K15 at high cell density. N-Terts were grown on coverslips at low (30%) or high (95%) cell densities in RM+. The cells were
fixed in formaldehyde and immunostained with antibodies against K15 (a, b), K14 (c, d), involucrin (e, f) and cornifin (g, h). All slides were
photographed at the same magnification. The insets in a and b were magnified in i and j, respectively, to show the presence of K15 aggregates,
shown by arrows, in keratinocytes grown at low cell density (magnification bar=20 mm).
doi:10.1371/journal.pone.0038599.g004
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culture conditions, for example, the biphasic nature of the profile
in RM+ (Fig. S1). This could be due to high concentration of EGF
in RM+, which has been shown to de-differentiate keratinocytes
and also suppress K15 expression [22,36]. With the other methods
of keratinocyte differentiation used in this study - high extracellular
calcium concentration, high cell densities and treatment with PMA
- the differentiation is either incomplete or can be reversed, with
little loss of proliferation. These differences were reflected in the
gene expression profiles, for example, the differentiation-specific
genes, K1, K10, cornifin and involucrin were induced in the
suspension culture whereas K14, a basal cell specific (or
proliferation specific) marker was suppressed (Fig. 1a). When
keratinocytes were differentiated at high cell density, K14 mRNA
unexpectedly increased with the increase in cell density (Fig. 3).
Although the basis for this observation was not clear, it has been
reported previously by others [54] that signalling generated by the
high cell density had an inductive effect on K14 similar to the
effect on differentiation-specific genes. Similarly, the mRNA and
protein levels of K15 did not increase proportionately when
keratinocytes were differentiated either by PMA or in suspension
culture. For example, in the suspension culture, the mRNA levels
of the differentiation markers (including K15) increased more than
100 fold, whereas increase in the protein level was only 2–3 fold
(compare Fig. 1a to 1c). This could be because either the mRNA
synthesised during differentiation is not translated into protein or
the protein is synthesised but because it is in excess of 1:1 ratio of
type I and type II polypeptides, they cannot assemble into
filaments. Any unassembled keratins are highly unstable and
removed by proteolysis. However, when keratinocytes were
Figure 5. Influence of PKC activator and inhibitor on the expression of K15 in keratinocytes. (a) N-Terts in RM
+ were exposed to different
concentrations of PMA (0–500 nM) or DMSO for 24 h and mRNA expression was determined by qPCR. (b) The keratinocytes were exposed overnight
to either 0 or 10 nM PMA, and protein levels were determined by western blotting. (c) N-Terts grown in SFM were suspended in 1.3% (w/v)
methylcellulose with no additive, 0.02% DMSO, or 5 mM PKC inhibitor GF109203X for 24 h and the cells were used to determine mRNA expression.
Freshly trypsinised single cell suspension of N-Terts was used as 0 h control cells. (d) N-Tert keratinocytes were suspended as in (c) with GF109203X
and protein expression at 0 h or 24 h was determined by western blotting. Each bar represents the mean6SEM where n=3. (P,0.01, very significant,
**; P,0.001, extremely significant, ***). For immunostaining N-Terts growing on glass coverslips in RM+ were treated with 10 nM PMA (f, h, j, l) or
DMSO control (e, g, i, k) for 24 h. The cells were fixed in 3.8% formaldehyde and immunostained with antibodies against K15 (e, f), K14 (g, h),
involucrin (i, j) and cornifin (k, l) (magnification bar=20 mm).
doi:10.1371/journal.pone.0038599.g005
Figure 6. Knocking down PKCd suppresses suspension-induced expression of K15. N-Terts were transfected separately with mock (no
oligo), control siRNA or siRNA for PKCd or PKCg. After 48 h of transfection, the cells were suspended in methylcellulose for 24 h, and used to
determine the mRNA expression of K15, PKCd and PKCg by qPCR. Each bar represents the mean6SEM where n=3. (P,0.05, significant, *; P,0.01,
very significant, **).
doi:10.1371/journal.pone.0038599.g006
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the protein was synthesised at a much higher level than that in
suspension culture (compare Fig. 1c with Fig. 5b). Furthermore,
two differentiation-specific markers K1 and K10 actually de-
creased by PMA (Fig. 5a), which is consistent with what has been
reported previously for these genes [55,56]. Although the
molecular basis for this observation is not clear, it may be that
PMA activates certain PKC isoforms, which suppress these genes,
or PMA triggers another mechanism with repressive effects on the
transcription of K1 and K10.
Comparing the expression of K14 with K15 in the suspension
culture suggests that, although the two genes are expressed in the
basal layer, K14 is suppressed, whereas K15 is induced at the
onset of terminal differentiation (Fig. 1a). This is the first report
that has shown that b1-integrin downregulation induces K15
transcription in the suspension culture. It can be argued that the
K15 induction was due to the cell cycle arrest rather than
keratinocyte differentiation. However, the presence of fibronectin
in the suspension culture is known to suppress differentiation
without preventing cell cycle arrest [43]. In this study, we found
that fibronectin and RGD peptide suppressed K15 expression,
suggesting that K15 induction in methylcellulose was due to
keratinocyte differentiation rather than cell cycle arrest. There are
several reports that suggest that K15 was a marker of epidermal
Figure 7. Role of AP-1 in the suspension-induced expression of K15. (a) Induction of K15 but suppression of K14 after 24 h suspension of N-
Terts in methylcellulose. (b) N-Terts were treated with different concentrations of SR11302 or DMSO before being suspended in methylcellulose. After
24 h, the cells were used to determine mRNA expression of K14 and K15. (c) HaCaT cells were transduced with retroviruses expressing TAM67 or the
pLPC vector control. After puromycin selection, the cells were suspended in methylcellulose for 24 h and used for gene expression analysis by qPCR.
Each bar represents the mean6SEM where n=3. (P,0.01, very significant, **; P,0.001 extremely significant, ***).
doi:10.1371/journal.pone.0038599.g007
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cells in the epidermis is uncertain; some reports say they are at the
tip of the rete ridges [52], whereas others point to their location
within the dermal papillae [57,58], while recent studies suggest
that they could be anywhere in the basal layer [59]. What is
certain, however, is that they give rise to TA cells, which move
laterally away from the stem cell zone to populate the basal layer.
Porter and co-workers suggested that K15 was not a stem cell
marker, but instead a marker of laterally differentiated keratino-
cytes [22]. However, lateral differentiation does not require
downregulation of b1-integrin, which is normally expressed
throughout the basal layer [60,61,62]. It is the vertical/terminal
differentiation that is triggered by the downregulation of b1-
integrin [8]. Our observation that in suspension, b1-integrins are
Figure 8. FOXM1B binding site on the K15 promoter. (a) K15 promoter divided into seven fragments (F1–F7) with the unique FOXM1B binding
motif (K15) and its comparison with the consensus sequence (con) is shown and the nucleotides in red highlight the differences. (b) X-chromatin
immunoprecipitation (X-ChIP): Primary human keratinocytes transduced with FOXM1B-GFP chimera were subjected to X-ChIP using FOXM1B and
GAPDH (as control) antibodies. The immunoprecipitated DNA was quantified by qPCR using primers specific for different regions (F1–F7) (see panel
a). All primers produced a single product (Melting peak) and the trace before (Total input) and after addition of FOXM1B (FOX) and GAPDH (GAP)
antibodies (IP Fraction) is shown. Data for only 3 primer sets are shown for clarity. (c) The DNA fragments immunoprecipitated with FOXM1B antibody
were quantified by qPCR. Each bar represents the mean6SEM where n=3.
doi:10.1371/journal.pone.0038599.g008
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K15 may also be a marker of keratinocytes undergoing vertical/
terminal differentiation under certain conditions.
Treatment of keratinocytes with PMA induces differentiation
and K15 expression (Fig. 5a), which is consistent with a recent
report that the PMA induced epidermal injury increases
suprabasal K15 expression [33]. Furthermore, treatment of
keratinocytes with the differentiating agent 2-(3,4,5-trimethoxy-
phenylamino)-pyrrolo[2,3-d] pyrimidine has been shown to induce
K15 transcription [63]. The involvement of PKC in the
transcriptional induction of K15 was demonstrated by the use of
PMA and a PKC inhibitor (Fig. 5). Amongst the PKC isoforms
that are expressed in keratinocytes, PKCd, PKCg and PKCe are
implicated in differentiation [64,65,66]. However, later studies
using siRNA have shown that only PKCd and PKCg are involved
[67]. In a recent study, the two isoforms inversely influenced the
expression of loricrin, a differentiation marker, PKCd inhibited,
whereas PKCg induced loricrin in differentiating keratinocytes
[68]. In this study, we found that knocking down PKCd by 80%
supressed K15 transcription by about 50%, whereas knocking
down PKCg was ineffective (Fig. 6). At first sight the siRNA knock
down data may appear inconsistent with PKC inhibitor
GF109203X (Fig. 5), which was highly potent in inhibiting K15
transcription, but the two methods are not comparable. The PKC
inhibitor will inhibit the enzyme activity, and therefore will always
be more potent, whereas siRNA will decrease the level of PKCd
protein by degrading its mRNA. Alternatively, it is conceivable
that the high potency of the GF109203X was due to inhibition of
other PKC isoforms in addition to PKCd. The activation of PKC
is known to induce AP-1 in keratinocytes (reviewed in [69]), which
is consistent with our observation that the inhibition of AP-1,
either by SR11302 or by dominant negative c-Jun, suppresses
suspension-induced K15 expression and it is also consistent with
the identification of an AP-1 binding motif in the K15 promoter
[42]. An intriguing observation was the suppression of K14
transcription in the suspension culture (Fig. 1, 5). On one hand the
suppression of K14 synthesis in differentiating keratinocytes is
consistent with what happens in vivo, but it is incompatible with
reports in the literature that the K14 promoter is induced by AP-1
[70]. If the suspension culture induces AP-1, as our data appears to
suggest (Fig. 7), then such treatment should also increase K14
expression. It is however conceivable that the AP-1 motif in the
K14 promoter, although able to biochemically respond to the AP-
1 [70], does not have a functional role in K14 expression, or its
effect is taken over by another de-differentiation-specific mecha-
nism in the basal layer.
Induction of K15 protein expression at high cellular densities
has been reported previously [22,41], however, the role of
transcriptional, post-transcriptional and post-translational mecha-
nisms in the K15 induction is not known [71,72,73]. This is the
first study where high keratinocyte density has been linked with
increased K15 gene transcription. We also show for the first time
that the K15 synthesised at a low cellular density exists as globules,
whereas at a high cell density, the filamentous form is predom-
inantly seen. The inability of globular K15 to integrate into pre-
existing K5/K14 filaments at low cell densities could be either due
to its low concentration or due to chemical modification, such as
phosphorylation. Whereas on one hand, the high cell density
induced keratinocyte differentiation is reportedly mediated
through PKC/AP-1 activation, which explains the basis for K15
induction at high cellular density [74,75], on the other hand
keratinocyte differentiation induced by high extracellular calcium
alone did not influence K15 expression (data not shown), as has
been reported by others [22]. This is interesting because high
calcium induced keratinocyte differentiation also involves the
PKC/AP-1 pathway [76] so why doesn’t calcium induce K15
transcription? It is possible that high calcium concentrations
activate a PKC isoform, which is unable to produce the correct
AP-1 (in terms of constituent Fos and Jun family members)
conducive to K15 induction. This hypothesis is consistent with
reports that PKC activation can produce different types of AP-1
complexes with different transcriptional specificities [76,77].
The PKC/AP-1 induced expression of K15 cannot explain the
basal-specific expression of K15 because most PKC isoforms and
the components of AP-1 are not expressed in the basal layer
[69,78]. The sonic hedgehog inducible transcription factor, Gli1,
could be involved, as it is expressed in the basal layer and is also
induced in BCCs along with K15 [22,32], but overexpression of
Gli1, either by retrovirus or by knocking down patch-1, does not
induce K15, indicating that Gli1 does not directly regulate K15
(Salima Mehboobali, unpublished observations). However, there
are several lines of evidence to suggest that FOXM1B, a
downstream target of Gli1 [79], could regulate K15 expression
in basal keratinocytes. First, FOXM1B and K15 are co-expressed
in the rete-ridges [44,52] and in the outer root sheath including
the bulge [80]. Second, K15 and FOXM1B are induced in BCCs
[22,32,79]. Third, FOXM1B is a cell cycle regulated protein and
is downregulated at the onset of differentiation [81,82]. Fourth,
K15 (but not K14) is induced when FOXM1B is overexpressed in
keratinocytes [44]. These reports are consistent with the identi-
fication of a FOXM1B binding site in the K15 promoter (Fig. 8).
Our results provide two putative mechanisms for K15 regulation,
one basal (driven by FOXM1) and another suprabasal (involving
PKC/AP-1) specific. These two mechanisms may not be
completely independent because PKC activation could downreg-
ulate FOXM1 at the onset of differentiation [82]. This may also
indicate different functions of K15 in the basal and suprabasal
compartments. In the basal layer, K15 could play a role in
signalling, proliferation and in cell-cell and cell-ECM interactions.
In the suprabasal layers, K15 could be associated with the extra
flexibility required in high traffic areas of the body, such as the
oesophagus.
FOXM1B is an oncogene that is highly expressed in most
cancers, which should also induce K15 in SCCs [44,81,83,84,85].
However, most published data suggests that K15 is suppressed in
SCCs [32,33]. These apparently contradictory observations could
be explained by the fact that oncogenic transformation is generally
accompanied with keratinocyte activation [86], which is reportedly
incompatible with K15 expression [21,36]. It is therefore plausible
that FOXM1B induced K15 expression in SCCs is subsequently
silenced by keratinocyte activation.
In conclusion, this study shows that keratinocytes differentiated
in methylcellulose or at a high cell density or by PMA induce K15
transcription. The suspension induced K15 expression involve
downregulation of b1-integrin and could be rescued by fibronectin
or RGD peptide, suggesting that K15 may be a marker of vertical/
terminal differentiation that was regulated by PKC/AP-1 signal-
ling. This would explain the basis for K15 expression in the
suprabasal layers of certain stratified epithelia and under certain
clinical situations. The basal expression of K15 must employ a
mechanism dependent on cell proliferation rather than differen-
tiation. We speculate that the basal cell/stem cell-specific
expression of K15 in the bulge and other tissues may involve
FOXM1B mediated signalling, which is supported by ectopic
expression, immuno-co-localisation and identification of a unique
FOXM1B binding motif in the K15 promoter. The fact that
keratinocytes undergoing terminal differentiation can also express
K15, as shown in this study, suggests that extreme caution should
Differentiation-Specific Expression of K15
PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e38599be exercised when interpreting results obtained from using K15 as
a marker of stem cell zones.
Materials and Methods
Telomerase (hTERT) and p16 immortalised normal human
skin keratinocytes N/Tert-1 [87] and normal human epidermal
keratinocytes derived from human neonatal foreskins (cat no.
12332-011, GIBCO Invitrogen) were cultured in serum free
medium (SFM) supplemented with 30 mg/ml of bovine pituitary
extract and 0.2 ng/ml of epidermal growth factor (EGF), while
HaCaT (a spontaneously immortalised cell line developed from
human adult skin [88]) keratinocytes were cultured in DMEM
+10% (v/v) foetal calf serum (FCS) and 1% (w/v) penicillin-
streptomycin. Methylcellulose 4000 cP, phorbol 12-myristate 13-
acetate, PMA (Sigma Aldrich, Dorset, UK), human plasma
fibronectin, RGD peptide, PKC inhibitor GF109203X (Calbio-
chem, Nottingham, UK), AP-1 inhibitor (E,E,Z,E)-3-Methyl-7-(4-
methylphenyl)-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)- 2,4,6,8-nona-
tetraenoic acid (SR11302) (Tocris Bioscience, UK), siRNA oligos
for human PKCd and PKCg (ON-TARGETplus SMARTpool),
DharmaFECT (Thermo Scientific, Lafayette, CO), Dynabeads
mRNA DIRECT kit (Invitrogen, UK), reverse transcription kit
(Promega, Southampton, UK), transfection agent TransIT-LT1
(Mirus Bio LLC, Madison, USA), DC protein assay kit (Bio-Rad,
Hemel Hempstead, UK) were obtained commercially. Gene
expression was quantified by real-time absolute qPCR on Light
Cycler LC480 using SyBR green (Roche Diagnostics Ltd, Burgess
Hill, UK). The antibodies used were: Rabbit monoclonal to K15
(EPR1614Y), mouse monoclonal to involucrin (SY5), mouse
monoclonal to cornifin (SPRR3), Rabbit polyclonal to GAPDH
(abcam, Cambridge, UK), anti-cytokeratin 14 LLOO2 (Cancer
Research UK), FOXM1B C-20 (Santa Cruz Biotechnology, Santa
Cruz, California, USA), horseradish peroxidase conjugated goat
anti-mouse or goat anti-rabbit (Millipore, Watford, UK), biotin
goat anti-mouse and biotin goat anti-rabbit (Sigma Aldrich), Alexa
FluorH 488 goat anti-mouse and Alexa FluorH 488 streptavidin
(Invitrogen). Western blots were detected using a chemilumines-
cence ECL kit (GE Healthcare, Amersham, UK).
Induction of Keratinocyte Differentiation by Suspension
in Methylcellulose
N-Terts (5610
5 cells) were suspended in 1.3% (w/v) methyl-
cellulose and plated in 6 cm bacteriological dishes coated with
0.4% (w/v) poly-2-hydroxyethyl methacrylate (polyHEMA) dis-
solved in a mixture of acetone and 95% ethanol (1:1). After
incubating the cell suspension for the required period, it was
diluted 10 fold with PBS and the cells were harvested by
centrifugation. The pellet was lysed either in 500 ml of lysis/
binding buffer to extract total mRNA or 200 ml of SDS sample
buffer for western blotting.
In some cases N-Terts were incubated with additives (fibronec-
tin, RGD, PKC inhibitor GF109203X, AP-1 inhibitor SR11302)
before being suspended in the methylcellulose. In every incident,
the influence of the effector was compared with the solvent in
which the effector was dissolved. After incubation for 24 h, the
cells were processed for gene expression by qPCR or for western
blotting.
Induction of Keratinocyte Differentiation at High Cell
Densities and by PMA
N-Terts cultured in SFM were plated at a density of 50,000 cells
in 6 cm culture dishes at low (0.09 mM) or high (1.8 mM) calcium
concentrations. The cells were cultured until they reached the
desired confluence and used for gene expression analysis. In some
experiments however, enough cells were plated to get the desired
cell density and after growing for 24 h, they were used for gene
expression analysis, or lysed in SDS buffer for western blotting.
N-Terts cultured in RM+ medium were plated in 6 cm culture
dishes and once attached, the cells were treated with different
concentration of PMA (0–500 nM) dissolved in DMSO. The final
DMSO concentration did not exceed 0.04% (v/v) in any of these
experiments. After 24 h, the cells were used for gene expression
and western blotting analyses.
Use of siRNA to Knockdown PKC Isoforms in Suspension
Cultures
N-Terts cultured in SFM at about 50% density were transfected
with 10–100 nmol siRNA using DharmaFECT transfection
reagent following the manufacturer’s instructions. The cells were
allowed to grow for 48 h after which they were suspended in
methylcellulose and harvested after 24 h for gene expression
analysis.
Immunofluorescence
Trypsinised N-Tert keratinocytes were seeded on sterile glass
coverslips at sub-confluence or 90% confluence and allowed to
attach overnight. Cells were treated with 10 nM PMA or with
DMSO (final concentration less than 0.04% v/v) for 24 h. The
cells were then fixed with 3.8% formaldehyde diluted in PBS for
10 min and permeabilised with 0.1% (v/v) Triton X-100 in PBS.
Cells were blocked with 10% normal goat serum diluted in PBS
+0.2% (v/v) Tween-20 (blocking solution) for 30 min and then
incubated overnight at 4uC with primary antibodies diluted in the
blocking solution. After washing three times with PBS +0.2% (v/v)
Tween-20 (PBS/Tween), the cells were incubated with biotin goat
anti-mouse or biotin goat anti-rabbit antibodies (depending upon
the nature of the primary antibody) for 2 h at room temperature.
For K14 the biotin step was omitted and the cells were directly
treated with Alexa FluorH 488 labelled goat anti-mouse. For the
rest of the antigens, the cells were washed three times as before
and incubated with Alexa FluorH 488 streptavidin diluted 1:100 in
the blocking solution for 1 h at room temperature. After washing
with PBS/Tween, the coverslips were treated with 5 mg/ml
propidium iodide for 1 min, before being mounted using Immuno-
mount and viewed in an immunofluorescence microscope using
appropriate filters.
To immunostain the differentiated keratinocytes, N-Terts were
suspended in methylcellulose for 24 h and harvested by dilution
and centrifugation as described above. The cell pellet was
suspended in 30 ml of FCS and 2–4 ml of the suspension was
streaked on glass slides (SuperFrost Plus, Thermo-Scientific) using
a pipette tip. Freshly trypsinised N-Terts that were not suspended
in methylcellulose were used as undifferentiated 0 h control. After
drying in air, the cells were fixed with formaldehyde and processed
for immunofluorescence as described above.
Gene Expression Analysis
Dynabeads mRNA DIRECT kit was used to extract the total
mRNA and was immediately converted to cDNA by reverse
transcription using a mixture of oligo dT and random hexamers
following the manufacturer’s instructions. Absolute real time
qPCR was performed for each gene as described previously [84].
Two internal reference genes (YAP1 and POLR2A) were used for
target gene normalization. The qPCR primer sequences for K1,
K10, K14, K15, involucrin, FOXM1B and cornifin have been
described previously [44] and those for b1-integrin, PKC isoforms
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cDNA was PCR amplified and sub-cloned in EcoRI/BamHI sites
of pLPC_cmyc vector (Addgene, Cambridge, USA) and the
construct was confirmed by sequencing. To generate replication
deficient amphotropic retrovirus supernatant, Phoenix A cells
were transfected with pLPC_cmyc-TAM67 construct using
TransIT-LT1 following the manufacturer’s instructions. After
72 h of transfection, the cells were selected in 2.5 mg/ml
puromycin until drug resistant colonies became visible. The
selection was continued until the cells reached confluence.
Retrovirus supernatants were collected from the confluence
cultures in the absence of puromycin and stored at 280uC for
future use. The transduction of keratinocytes using recombinant
retrovirus supernatant was carried out using 5 mg/ml hexadi-
methrine bromide (polybrene) as described previously [84]. The
transduced cells were selected in 2.5 mg/ml puromycin until a
stable culture was established.
Other Methods
Protein concentration was determined using the Bio-Rad DC
protein assay kit. Cell counting was carried out using a
haemocytometer. SDS electrophoresis was performed on 4–12%
gradient gels (Invitrogen) in Bis-Tris buffer. For western blotting,
the proteins were transferred electrophoretically onto nitrocellu-
lose membranes. After probing with 1
st and 2
nd antibodies, the
membranes were developed using Amersham ECL Western
Blotting detection system.
Statistical Analysis
Student’s t-tests were performed using Microsoft Excel and all
results are presented as the mean of 3 individual experiments with
standard error of mean (S.E.M). The P-value was calculated and
was considered significant if below 0.05.
Supporting Information
Figure S1 Differentiation of primary human keratino-
cytes in suspension. (a) N-Terts and (b) normal primary
human epidermal keratinocytes growing in RM
+ +10% FCS were
suspended in DMEM +20% FCS containing 1.3% (w/v)
methylcellulose. At different time intervals, cells were harvested
and used to determine mRNA expression by qPCR. The RM
+
medium contains 10 ng/ml EGF compared to 0.2 ng/ml in SFM.
The initial de-differentiation phase in the graph could be due to
the large excess of EGF in RM
+. Each bar represents the
mean6SEM where n=3.
(TIF)
Figure S2 Induction of K15 transcription in HaCaT at
high cell density. (a) HaCaT keratinocytes were grown at low
(30%) and high (95%) confluence at low calcium (0.09 mM)
concentration for 24 h after which the cells were lysed to
determine the mRNA expression. (b) The cells grown at low (S)
and high (C) densities were analyzed by western blotting for
expression of K14, K15 and involucrin. Each bar represents the
mean6SEM where n=3. (P,0.01, very significant, **; P,0.001,
extremely significant, ***).
(TIF)
Figure S3 Induction of PKCd and PKCg transcription in
suspension culture. N-Terts grown in SFM were suspended in
DMEM +10% FCS containing 1.3% (w/v) methylcellulose. After
24 h the cells were harvested to determine the mRNA levels of
PKCa, PKCd, PKCg, PKCf and PKCe by qPCR. Each bar
represents the mean6SEM where n=3. (P,0.01, very significant,
**; P,0.001, extremely significant, ***).
(TIF)
Table S1 Oligonucleotides used in this study.
(TIF)
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